40
Participants
Start Date
May 2, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2025
Liraglutide
"Dosing regimen: In this study protocol, liraglutide dosing will be implemented as follows: Liraglutide will be started at a dose of 0.6 mg per day. Participants will be taught to use the injection pen and will be observed giving the first injection. The dose will then be increased by 0.6 mg each week to a maximum dosage of 3.0 mg per day at the end of 4 weeks.~This corresponds to the following dosing schedule:~Week 1: 0.6 mg per day for one week Week 2: 1.2 mg per day for one week Week 3: 1.8 mg per day for one week Week 4: 2.4 mg per day for one week Week 5-12: 3.0 mg per day for 8 weeks Week 13-24: No drug administration"
RECRUITING
Africa Health Research Institute Clinical Trials Unit, Mtubatuba
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Brigham and Women's Hospital
OTHER